Storebrand Asset Management AS
Lysaker, 15 January 2021
Financial Calender 2021
| Fund name and share class | Symbol | ISIN |
| Storebrand Indeks – Alle Markeder A5 | STIIAM | NO0010841588 |
| Storebrand Indeks – Nye Markeder A5 | STIINM | NO0010841570 |
| Storebrand Global ESG Plus A5 | STIGEP | NO0010841604 |
| Storebrand Global Solutions A5 | STIGS | NO0010841612 |
| Storebrand Global Multifactor A5 | STIGM | NO0010841596 |
FINANCIAL YEAR 2020
23.04.2021 – Annual Report
FINANCIAL YEAR 2021
24.03.2021 – Election meeting
13.07.2021 – Semi annual Report
29.04.2022 – Annual Report
The funds listed on Nasdaq Copenhagen will be available for trading during the Nasdaq opening hours. Jyske Bank is acting as the market maker, and will ensure transferability for the funds.
For queries, you may contact Storebrand's Danish branch on +45 33 41 76 53, or Kim.Toftegaard.Andreassen@storebrand.com
Regards
Storebrand Asset Management AS
Contacts:
Kim Toftegaard Andreassen, Director, +45 33 41 76 53
Frode Aasen, Product Manager, +47 934 03 934
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bavarian Nordic A/S6.11.2025 15:03:23 CET | Press release
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
Bavarian Nordic A/S6.11.2025 15:03:23 CET | Pressemeddelelse
Konsortium bestående af Nordic Capital og Permira offentliggør det foreløbige resultat af overtagelsestilbuddet til aktionærerne i Bavarian Nordic og at Tilbuddet tilbagekaldes og ikke vil blive gennemført
Investeringsforeningen Wealth Invest6.11.2025 15:02:04 CET | Press release
Meddelelse om fejl NAV i Wealth Invest AlphaCura
Alvotech6.11.2025 15:00:00 CET | Press release
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
Scatec ASA6.11.2025 14:49:25 CET | Press release
Scatec JV in the Philippines awarded 68 MW floating solar project
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
